Ignite Creation Date:
2024-05-06 @ 9:58 AM
Last Modification Date:
2024-10-26 @ 12:22 PM
Study NCT ID:
NCT03125876
Status:
TERMINATED
Last Update Posted:
2021-03-24
First Post:
2017-04-09
Brief Title:
A Phase Ib Study of CT053PTSA in Relapsed Refractory Acute Myeloid Leukemia AML
Sponsor:
Sunshine Lake Pharma Co Ltd
Organization:
Sunshine Lake Pharma Co Ltd
Organization Data
Organization:
Sunshine Lake Pharma Co Ltd
Class:
INDUSTRY
Study ID:
PCD-DCT053-16-002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Sunshine Lake Pharma Co Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None